IP Library Assignment 042489/0434
Patent Assignment
Reel/Frame 042489/0434

General Conveyance and Assumption Agreement

Recorded: 2017-05-17 Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Substituted Bicyclic Compounds as Bromodomain Inhibitors
Application: 15/459,886 →
Publication: US 2017/0182029
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 17, 2017
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 042414/0982 →
Assignment of Assignor's Interest May 17, 2017
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 042415/0029 →
Assignment of Assignor's Interest May 17, 2017
From: LIU, SHUANG; QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 042489/0359 →
Change of Name May 17, 2017
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 042489/0446 →